TreeWAS – Variant ID: rs2071470

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E10.9 Without complications	0.000	0.000	1.000
J45.9 Asthma, unspecified	0.000	0.000	1.000
K90.0 Coeliac disease	0.000	0.000	1.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
L40.5 Arthropathic psoriasis	1.000	0.000	0.000
E10 Insulin-dependent diabetes mellitus	0.000	0.000	1.000
L40 Psoriasis	1.000	0.000	0.000
E00-E07 Disorders of thyroid gland	0.000	0.000	1.000
E03.9 Hypothyroidism, unspecified	0.000	0.000	1.000
E03 Other hypothyroidism	0.000	0.000	1.000
E10.3 With ophthalmic complications	0.000	0.001	0.999
E10.1 With ketoacidosis	0.000	0.001	0.999
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.001	0.999
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.004	0.996
E10-E14 Diabetes mellitus	0.000	0.004	0.996
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.005	0.995
I25 Chronic ischaemic heart disease	0.991	0.009	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.990	0.010	0.000
C44 Other malignant neoplasms of skin	0.988	0.012	0.000
C44.2 Skin of ear and external auricular canal	0.986	0.014	0.000
E10.4 With neurological complications	0.000	0.015	0.985
I25.9 Chronic ischaemic heart disease, unspecified	0.983	0.017	0.000
C44.7 Skin of lower limb, including hip	0.976	0.024	0.000
I20-I25 Ischaemic heart diseases	0.976	0.024	0.000
E05.9 Thyrotoxicosis, unspecified	0.000	0.024	0.976
C44.4 Skin of scalp and neck	0.974	0.026	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.033	0.967
C44.3 Skin of other and unspecified parts of face	0.962	0.038	0.000
I21 Acute myocardial infarction	0.952	0.048	0.000
E16 Other disorders of pancreatic internal secretion	0.000	0.053	0.947
E10.2 With renal complications	0.000	0.055	0.945
I25.2 Old myocardial infarction	0.937	0.063	0.000
I21.9 Acute myocardial infarction, unspecified	0.933	0.067	0.000
I24 Other acute ischaemic heart diseases	0.932	0.068	0.000
E10.8 With unspecified complications	0.000	0.069	0.931
E16.2 Hypoglycaemia, unspecified	0.000	0.069	0.931
E10.0 With coma	0.000	0.104	0.896
E07 Other disorders of thyroid	0.000	0.108	0.892
I21.2 Acute transmural myocardial infarction of other sites	0.885	0.115	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.120	0.880
C44.5 Skin of trunk	0.877	0.123	0.000
I24.8 Other forms of acute ischaemic heart disease	0.876	0.124	0.000
L40.0 Psoriasis vulgaris	0.867	0.132	0.000
L40.1 Generalised pustular psoriasis	0.856	0.144	0.000
I21.1 Acute transmural myocardial infarction of inferior wall	0.852	0.148	0.000
I25.3 Aneurysm of heart	0.846	0.154	0.000
I23 Certain current complications following acute myocardial infarction	0.838	0.162	0.000
E10.6 With other specified complications	0.000	0.170	0.830
E40-E46 Malnutrition	0.000	0.191	0.809
I24.9 Acute ischaemic heart disease, unspecified	0.807	0.193	0.000
L40.4 Guttate psoriasis	0.800	0.200	0.000
I22 Subsequent myocardial infarction	0.799	0.201	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.202	0.798
E14 Unspecified diabetes mellitus	0.000	0.222	0.778
C44.0 Skin of lip	0.773	0.227	0.000
L40.8 Other psoriasis	0.761	0.239	0.000
I22.1 Subsequent myocardial infarction of inferior wall	0.760	0.240	0.000
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.734	0.266	0.000
E10.5 With peripheral circulatory complications	0.000	0.269	0.731
C44.9 Malignant neoplasm of skin, unspecified	0.726	0.274	0.000
E10.7 With multiple complications	0.000	0.283	0.717
L40.3 Pustulosis palmaris et plantaris	0.717	0.283	0.000
L40.2 Acrodermatitis continua	0.717	0.283	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.283	0.717
E00 Congenital iodine-deficiency syndrome	0.000	0.283	0.717
E03.5 Myxoedema coma	0.000	0.283	0.717
E03.4 Atrophy of thyroid (acquired)	0.000	0.283	0.717
E03.3 Postinfectious hypothyroidism	0.000	0.283	0.717
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.283	0.717
E05.5 Thyroid crisis or storm	0.000	0.284	0.716
E05.4 Thyrotoxicosis factitia	0.000	0.284	0.716
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.284	0.716
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.284	0.716
E12 Malnutrition-related diabetes mellitus	0.000	0.286	0.714
E03.1 Congenital hypothyroidism without goitre	0.000	0.289	0.711
I25.6 Silent myocardial ischaemia	0.710	0.289	0.000
C44.8 Overlapping lesion of skin	0.708	0.292	0.000
K90 Intestinal malabsorption	0.000	0.295	0.705
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.307	0.693
E15 Nondiabetic hypoglycaemic coma	0.000	0.307	0.693
E16.1 Other hypoglycaemia	0.000	0.307	0.692
E07.8 Other specified disorders of thyroid	0.000	0.314	0.685
I21.X Presumed acute myicardial infaction (unconfirmed)	0.683	0.317	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.321	0.679
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.321	0.679
E16.4 Abnormal secretion of gastrin	0.000	0.321	0.679
E16.3 Increased secretion of glucagon	0.000	0.321	0.679
E46 Unspecified protein-energy malnutrition	0.000	0.324	0.676
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.659	0.341	0.000
J45 Asthma	0.000	0.344	0.656
M07.39 Other psoriatic arthropathies (Site unspecified)	0.656	0.344	0.000
M07.3 Other psoriatic arthropathies	0.652	0.348	0.000
E14.3 With ophthalmic complications	0.000	0.350	0.650
I25.0 Atherosclerotic cardiovascular disease, so described	0.643	0.357	0.000
E03.8 Other specified hypothyroidism	0.000	0.359	0.641
E07.1 Dyshormogenetic goitre	0.000	0.360	0.640
E07.0 Hypersecretion of calcitonin	0.000	0.360	0.640
M07.30 Other psoriatic arthropathies (Multiple sites)	0.637	0.363	0.000
E05.8 Other thyrotoxicosis	0.000	0.373	0.627
I21.3 Acute transmural myocardial infarction of unspecified site	0.626	0.373	0.000
I24.1 Dressler's syndrome	0.624	0.376	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.618	0.382	0.000
E14.8 With unspecified complications	0.000	0.383	0.617
I23.8 Other current complications following acute myocardial infarction	0.616	0.384	0.000
L40-L45 Papulosquamous disorders	0.613	0.387	0.000
E50-E64 Other nutritional deficiencies	0.000	0.395	0.604
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.396	0.604
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.601	0.399	0.000
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.601	0.399	0.000
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.601	0.399	0.000
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.601	0.399	0.000
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.601	0.399	0.000
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.601	0.399	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.409	0.591
I25.4 Coronary artery aneurysm	0.588	0.412	0.000
J45.0 Predominantly allergic asthma	0.000	0.414	0.586
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.419	0.581
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.420	0.580
E45 Retarded development following protein-energy malnutrition	0.000	0.420	0.580
E43 Unspecified severe protein-energy malnutrition	0.000	0.420	0.580
E42 Marasmic kwashiorkor	0.000	0.420	0.580
E41 Nutritional marasmus	0.000	0.420	0.580
E40 Kwashiorkor	0.000	0.420	0.580
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.575	0.425	0.000
E14.6 With other specified complications	0.000	0.426	0.574
M07.36 Other psoriatic arthropathies (Lower leg)	0.570	0.430	0.000
E14.5 With peripheral circulatory complications	0.000	0.435	0.565
I25.5 Ischaemic cardiomyopathy	0.564	0.436	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.560	0.440	0.000
K90.8 Other intestinal malabsorption	0.000	0.440	0.559
E14.7 With multiple complications	0.000	0.442	0.558
E14.2 Withrenal complications	0.000	0.442	0.558
E14.0 With coma	0.000	0.442	0.558
I22.0 Subsequent myocardial infarction of anterior wall	0.556	0.444	0.000
C82.0 Small cleaved cell, follicular	0.544	0.456	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.539	0.461	0.000
I22.8 Subsequent myocardial infarction of other sites	0.539	0.461	0.000
K90.9 Intestinal malabsorption, unspecified	0.000	0.468	0.532
E14.1 With ketoacidosis	0.000	0.470	0.530
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.486	0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.486	0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.486	0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.486	0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.486	0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.486	0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.486	0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.486	0.514
E12.9 Without complications	0.000	0.488	0.512
E12.8 With unspecified complications	0.000	0.488	0.512
E12.7 With multiple complications	0.000	0.488	0.512
E12.6 With other specified complications	0.000	0.488	0.512
E12.5 With peripheral circulatory complications	0.000	0.488	0.512
E12.4 With neurological complications	0.000	0.488	0.512
E12.3 With ophthalmic complications	0.000	0.488	0.512
E12.2 With renal complications	0.000	0.488	0.512
E12.1 With ketoacidosis	0.000	0.488	0.512
E12.0 With coma	0.000	0.488	0.512
K90.3 Pancreatic steatorrhoea	0.000	0.495	0.505
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.495	0.505
K90.1 Tropical sprue	0.000	0.495	0.505
E14.4 With neurological complications	0.000	0.503	0.497
E53 Deficiency of other B group vitamins	0.000	0.503	0.497
L43 Lichen planus	0.493	0.507	0.000
E14.9 Without complications	0.000	0.508	0.492
I25.1 Atherosclerotic heart disease	0.491	0.509	0.000
E13 Other specified diabetes mellitus	0.000	0.510	0.489
M07.31 Other psoriatic arthropathies (Shoulder region)	0.483	0.517	0.000
L42 Pityriasis rosea	0.475	0.525	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.474	0.525	0.000
J45.8 Mixed asthma	0.000	0.529	0.470
J45.1 Nonallergic asthma	0.000	0.529	0.470
C82.3 Follicular lymphoma grade IIIa	0.470	0.530	0.000
M07.38 Other psoriatic arthropathies (Other)	0.468	0.532	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.468	0.532	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.468	0.532	0.000
L41 Parapsoriasis	0.465	0.535	0.000
C82.2 Large cell, follicular	0.455	0.545	0.000
E65-E68 Obesity and other hyperalimentation	0.000	0.545	0.455
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.452	0.547	0.000
C44.1 Skin of eyelid, including canthus	0.446	0.554	0.000
L44 Other papulosquamous disorders	0.440	0.560	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.440	0.560	0.000
C82.4 Follicular lymphoma grade IIIb	0.435	0.565	0.000
E61 Deficiency of other nutrient elements	0.000	0.565	0.435
E64 Sequelae of malnutrition and other nutritional deficiencies	0.000	0.566	0.433
E63 Other nutritional deficiencies	0.000	0.566	0.433
E56 Other vitamin deficiencies	0.000	0.566	0.433
E50 Vitamin A deficiency	0.000	0.566	0.433
E60 Dietary zinc deficiency	0.000	0.566	0.433
E59 Dietary selenium deficiency	0.000	0.566	0.433
E54 Ascorbic acid deficiency	0.000	0.566	0.433
E52 Niacin deficiency [pellagra]	0.000	0.566	0.433
E53.8 Deficiency of other specified B group vitamins	0.000	0.567	0.433
L43.9 Lichen planus, unspecified	0.424	0.576	0.000
E51 Thiamine deficiency	0.000	0.576	0.423
E44.1 Mild protein-energy malnutrition	0.000	0.584	0.416
E44.0 Moderate protein-energy malnutrition	0.000	0.584	0.416
C82.6 Cutaneous follicle centre lymphoma	0.413	0.587	0.000
C82.5 Diffuse follicle centre lymphoma	0.413	0.587	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.405	0.595	0.000
E58 Dietary calcium deficiency	0.000	0.626	0.374
L41.1 Pityriasis lichenoides chronica	0.358	0.642	0.000
E53.1 Pyridoxine deficiency	0.000	0.644	0.356
E53.0 Riboflavin deficiency	0.000	0.644	0.356
L43.3 Subacute (active) lichen planus	0.353	0.647	0.000
L43.2 Lichenoid drug reaction	0.353	0.647	0.000
L43.1 Bullous lichen planus	0.353	0.647	0.000
L43.0 Hypertrophic lichen planus	0.353	0.647	0.000
E13.8 With unspecified complications	0.000	0.649	0.351
E13.7 With multiple complications	0.000	0.649	0.351
E13.6 With other specified complications	0.000	0.649	0.351
E13.5 With peripheral circulatory complications	0.000	0.649	0.351
E13.4 With neurological complications	0.000	0.649	0.351
E13.2 With renal complications	0.000	0.649	0.351
E13.1 With ketoacidosis	0.000	0.649	0.351
E13.0 With coma	0.000	0.649	0.351
E06 Thyroiditis	0.001	0.654	0.346
E61.2 Magnesium deficiency	0.000	0.661	0.339
L41.9 Parapsoriasis, unspecified	0.333	0.667	0.000
L41.8 Other parapsoriasis	0.333	0.667	0.000
L41.5 Retiform parapsoriasis	0.333	0.667	0.000
L41.4 Large plaque parapsoriasis	0.333	0.667	0.000
L41.3 Small plaque parapsoriasis	0.333	0.667	0.000
L41.2 Lymphomatoid papulosis	0.333	0.667	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.333	0.667	0.000
E53.9 Vitamin B deficiency, unspecified	0.000	0.673	0.327
E67 Other hyperalimentation	0.000	0.674	0.326
E68 Sequelae of hyperalimentation	0.000	0.674	0.326
L43.8 Other lichen planus	0.316	0.684	0.000
L44.9 Papulosquamous disorder, unspecified	0.315	0.684	0.000
L44.8 Other specified papulosquamous disorders	0.315	0.684	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.315	0.684	0.000
L44.3 Lichen ruber moniliformis	0.315	0.684	0.000
L44.2 Lichen striatus	0.315	0.684	0.000
L44.1 Lichen nitidus	0.315	0.684	0.000
L44.0 Pityriasis rubra pilaris	0.315	0.684	0.000
E61.9 Deficiency of nutrient element, unspecified	0.000	0.688	0.312
E61.8 Deficiency of other specified nutrient elements	0.000	0.688	0.312
E61.7 Deficiency of multiple nutrient elements	0.000	0.688	0.312
E61.6 Vanadium deficiency	0.000	0.688	0.312
E61.5 Molybdenum deficiency	0.000	0.688	0.312
E61.4 Chromium deficiency	0.000	0.688	0.312
E61.3 Manganese deficiency	0.000	0.688	0.312
E61.0 Copper deficiency	0.000	0.688	0.312
E13.3 With ophthalmic complications	0.000	0.689	0.311
E50.9 Vitamin A deficiency, unspecified	0.000	0.689	0.311
E50.8 Other manifestations of vitamin A deficiency	0.000	0.689	0.311
E50.7 Other ocular manifestations of vitamin A deficiency	0.000	0.689	0.311
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.000	0.689	0.311
E50.5 Vitamin A deficiency with night blindness	0.000	0.689	0.311
E50.4 Vitamin A deficiency with keratomalacia	0.000	0.689	0.311
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.000	0.689	0.311
E50.2 Vitamin A deficiency with corneal xerosis	0.000	0.689	0.311
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.000	0.689	0.311
E50.0 Vitamin A deficiency with conjunctival xerosis	0.000	0.689	0.311
E56.9 Vitamin deficiency, unspecified	0.000	0.689	0.311
E56.8 Deficiency of other vitamins	0.000	0.689	0.311
E56.1 Deficiency of vitamin K	0.000	0.689	0.311
E56.0 Deficiency of vitamin E	0.000	0.689	0.311
E63.9 Nutritional deficiency, unspecified	0.000	0.689	0.311
E63.8 Other specified nutritional deficiencies	0.000	0.689	0.311
E63.1 Imbalance of constituents of food intake	0.000	0.689	0.311
E63.0 Essential fatty acid [EFA] deficiency	0.000	0.689	0.311
E64.9 Sequelae of unspecified nutritional deficiency	0.000	0.689	0.311
E64.8 Sequelae of other nutritional deficiencies	0.000	0.689	0.311
E64.3 Sequelae of rickets	0.000	0.689	0.311
E64.2 Sequelae of vitamin C deficiency	0.000	0.689	0.311
E64.1 Sequelae of vitamin A deficiency	0.000	0.689	0.311
E64.0 Sequelae of protein-energy malnutrition	0.000	0.689	0.311
E51.9 Thiamine deficiency, unspecified	0.000	0.696	0.304
E51.8 Other manifestations of thiamine deficiency	0.000	0.696	0.304
E51.1 Beriberi	0.000	0.696	0.304
E51.2 Wernicke's encephalopathy	0.000	0.706	0.294
I20 Angina pectoris	0.292	0.708	0.000
E55 Vitamin D deficiency	0.000	0.710	0.290
E61.1 Iron deficiency	0.000	0.721	0.279
M07 Psoriatic and enteropathic arthropathies	0.278	0.722	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.261	0.739	0.000
E66 Obesity	0.000	0.740	0.260
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.000	0.743	0.257
E06.4 Drug-induced thyroiditis	0.001	0.752	0.248
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.001	0.752	0.248
E06.1 Subacute thyroiditis	0.001	0.752	0.248
E06.0 Acute thyroiditis	0.001	0.752	0.248
I20.1 Angina pectoris with documented spasm	0.241	0.759	0.000
E66.8 Other obesity	0.000	0.764	0.236
I21.4 Acute subendocardial myocardial infarction	0.234	0.766	0.000
E67.8 Other specified hyperalimentation	0.000	0.766	0.234
E67.3 Hypervitaminosis D	0.000	0.766	0.234
E67.2 Megavitamin-B6 syndrome	0.000	0.766	0.234
E67.1 Hypercarotenaemia	0.000	0.766	0.234
E67.0 Hypervitaminosis A	0.000	0.766	0.234
D51 Vitamin B12 deficiency anaemia	0.000	0.771	0.229
E06.5 Other chronic thyroiditis	0.001	0.776	0.223
C44.6 Skin of upper limb, including shoulder	0.224	0.776	0.000
E13.9 Without complications	0.000	0.792	0.208
E55.0 Rickets, active	0.000	0.792	0.208
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.000	0.795	0.205
I22.9 Subsequent myocardial infarction of unspecified site	0.205	0.795	0.000
M07.6 Other enteropathic arthropathies	0.200	0.800	0.000
M07.5 Arthropathy in ulcerative colitis	0.200	0.800	0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.200	0.800	0.000
M07.2 Psoriatic spondylitis	0.200	0.800	0.000
M07.1 Arthritis mutilans	0.200	0.800	0.000
M07.0 Distal interphalangeal psoriatic arthropathy	0.200	0.800	0.000
E65 Localised adiposity	0.001	0.801	0.198
E66.1 Drug-induced obesity	0.000	0.813	0.187
D50-D53 Nutritional anaemias	0.000	0.817	0.183
E06.9 Thyroiditis, unspecified	0.001	0.825	0.174
D52 Folate deficiency anaemia	0.000	0.835	0.165
E66.2 Extreme obesity with alveolar hypoventilation	0.000	0.835	0.164
D51.8 Other vitamin B12 deficiency anaemias	0.000	0.835	0.165
D51.2 Transcobalamin II deficiency	0.000	0.835	0.165
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria	0.000	0.835	0.165
D51.3 Other dietary vitamin B12 deficiency anaemia	0.000	0.844	0.156
I20.0 Unstable angina	0.155	0.845	0.000
D52.9 Folate deficiency anaemia, unspecified	0.000	0.847	0.153
E66.0 Obesity due to excess calories	0.000	0.851	0.149
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)	0.143	0.857	0.000
M07.08 Distal interphalangeal proriatic arthropathy-Other	0.143	0.857	0.000
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)	0.143	0.857	0.000
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg	0.143	0.857	0.000
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh	0.143	0.857	0.000
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)	0.143	0.857	0.000
M07.03 Distal interphalangeal proriatic arthropathy-Forearm	0.143	0.857	0.000
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm	0.143	0.857	0.000
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region	0.143	0.857	0.000
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)	0.143	0.857	0.000
M07.19 Arthritis mutilans (Site unspecified)	0.143	0.857	0.000
M07.18 Arthritis mutilans (Other)	0.143	0.857	0.000
M07.17 Arthritis mutilans (Ankle and foot)	0.143	0.857	0.000
M07.16 Arthritis mutilans (Lower leg)	0.143	0.857	0.000
M07.15 Arthritis mutilans (Pelvic region and thigh)	0.143	0.857	0.000
M07.14 Arthritis mutilans (Hand)	0.143	0.857	0.000
M07.13 Arthritis mutilans (Forearm)	0.143	0.857	0.000
M07.12 Arthritis mutilans (Upper arm)	0.143	0.857	0.000
M07.11 Arthritis mutilans (Shoulder region)	0.143	0.857	0.000
M07.10 Arthritis mutilans (Multiple sites)	0.143	0.857	0.000
M07.29 Psoriatic spondylitis (Site unspecified)	0.143	0.857	0.000
M07.28 Psoriatic spondylitis (Other)	0.143	0.857	0.000
M07.27 Psoriatic spondylitis (Ankle and foot)	0.143	0.857	0.000
M07.26 Psoriatic spondylitis (Lower leg)	0.143	0.857	0.000
M07.25 Psoriatic spondylitis (Pelvic region and thigh)	0.143	0.857	0.000
M07.24 Psoriatic spondylitis (Hand)	0.143	0.857	0.000
M07.23 Psoriatic spondylitis (Forearm)	0.143	0.857	0.000
M07.22 Psoriatic spondylitis (Upper arm)	0.143	0.857	0.000
M07.21 Psoriatic spondylitis (Shoulder region)	0.143	0.857	0.000
M07.20 Psoriatic spondylitis (Multiple sites)	0.143	0.857	0.000
M07.49 Arthropathy in Crohn's disease [regional enteritis] (Site unspecified)	0.143	0.857	0.000
M07.48 Arthropathy in Crohn's disease [regional enteritis] (Other)	0.143	0.857	0.000
M07.47 Arthropathy in Crohn's disease [regional enteritis] (Ankle and foot)	0.143	0.857	0.000
M07.46 Arthropathy in Crohn's disease [regional enteritis] (Lower leg)	0.143	0.857	0.000
M07.45 Arthropathy in Crohn's disease [regional enteritis] (Pelvic region and thigh)	0.143	0.857	0.000
M07.44 Arthropathy in Crohn's disease [regional enteritis] (Hand)	0.143	0.857	0.000
M07.43 Arthropathy in Crohn's disease [regional enteritis] (Forearm)	0.143	0.857	0.000
M07.42 Arthropathy in Crohn's disease [regional enteritis] (Upper arm)	0.143	0.857	0.000
M07.41 Arthropathy in Crohn's disease [regional enteritis] (Shoulder region)	0.143	0.857	0.000
M07.40 Arthropathy in Crohn's disease [regional enteritis] (Multiple sites)	0.143	0.857	0.000
M07.59 Arthropathy in ulcerative colitis (Site unspecified)	0.143	0.857	0.000
M07.58 Arthropathy in ulcerative colitis (Other)	0.143	0.857	0.000
M07.57 Arthropathy in ulcerative colitis (Ankle and foot)	0.143	0.857	0.000
M07.56 Arthropathy in ulcerative colitis (Lower leg)	0.143	0.857	0.000
M07.55 Arthropathy in ulcerative colitis (Pelvic region and thigh)	0.143	0.857	0.000
M07.54 Arthropathy in ulcerative colitis (Hand)	0.143	0.857	0.000
M07.53 Arthropathy in ulcerative colitis (Forearm)	0.143	0.857	0.000
M07.52 Arthropathy in ulcerative colitis (Upper arm)	0.143	0.857	0.000
M07.51 Arthropathy in ulcerative colitis (Shoulder region)	0.143	0.857	0.000
M07.50 Arthropathy in ulcerative colitis (Multiple sites)	0.143	0.857	0.000
M07.69 Other enteropathic arthropathies (Site unspecified)	0.143	0.857	0.000
M07.68 Other enteropathic arthropathies (Other)	0.143	0.857	0.000
M07.67 Other enteropathic arthropathies (Ankle and foot)	0.143	0.857	0.000
M07.66 Other enteropathic arthropathies (Lower leg)	0.143	0.857	0.000
M07.65 Other enteropathic arthropathies (Pelvic region and thigh)	0.143	0.857	0.000
M07.64 Other enteropathic arthropathies (Hand)	0.143	0.857	0.000
M07.63 Other enteropathic arthropathies (Forearm)	0.143	0.857	0.000
M07.62 Other enteropathic arthropathies (Upper arm)	0.143	0.857	0.000
M07.61 Other enteropathic arthropathies (Shoulder region)	0.143	0.857	0.000
M07.60 Other enteropathic arthropathies (Multiple sites)	0.143	0.857	0.000
D53 Other nutritional anaemias	0.000	0.861	0.139
E06.3 Autoimmune thyroiditis	0.001	0.868	0.131
D50 Iron deficiency anaemia	0.000	0.873	0.127
I20.9 Angina pectoris, unspecified	0.124	0.876	0.000
T42.4 Benzodiazepines	0.122	0.878	0.000
I21.0 Acute transmural myocardial infarction of anterior wall	0.120	0.880	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.119	0.881	0.000
D52.8 Other folate deficiency anaemias	0.000	0.881	0.119
D52.1 Drug-induced folate deficiency anaemia	0.000	0.881	0.119
D52.0 Dietary folate deficiency anaemia	0.000	0.881	0.119
T43.2 Other and unspecified antidepressants	0.119	0.881	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.115	0.885	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.112	0.888	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.108	0.892	0.000
D53.9 Nutritional anaemia, unspecified	0.000	0.892	0.108
T50.9 Other and unspecified drugs, medicaments and biological substances	0.107	0.893	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.104	0.896	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.104	0.896	0.000
D53.8 Other specified nutritional anaemias	0.000	0.900	0.100
D53.2 Scorbutic anaemia	0.000	0.900	0.100
D53.1 Other megaloblastic anaemias, not elsewhere classified	0.000	0.900	0.100
D53.0 Protein deficiency anaemia	0.000	0.900	0.100
D50.8 Other iron deficiency anaemias	0.000	0.901	0.099
W19.9 Unspecified place	0.000	0.903	0.097
D50.9 Iron deficiency anaemia, unspecified	0.000	0.903	0.097
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.096	0.904	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.093	0.907	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.092	0.907	0.000
D50.1 Sideropenic dysphagia	0.000	0.909	0.091
T42.0 Hydantoin derivatives	0.090	0.910	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.090	0.910	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.087	0.913	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.086	0.914	0.000
T42.3 Barbiturates	0.086	0.914	0.000
T42.2 Succinimides and oxazolidinediones	0.086	0.914	0.000
T42.1 Iminostilbenes	0.086	0.914	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.084	0.916	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.084	0.916	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.083	0.917	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.083	0.917	0.000
T43.9 Psychotropic drug, unspecified	0.083	0.917	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.083	0.917	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.080	0.919	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.080	0.919	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.079	0.921	0.000
T50.7 Analeptics and opioid receptor antagonists	0.078	0.922	0.000
T50.5 Appetite depressants	0.078	0.922	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.078	0.922	0.000
T50.1 Loop [high-ceiling] diuretics	0.078	0.922	0.000
T50.0 Mineralocorticoids and their antagonists	0.078	0.922	0.000
I45.1 Other and unspecified right bundle-branch block	0.000	0.922	0.078
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.924	0.076
C90 Multiple myeloma and malignant plasma cell neoplasms	0.075	0.925	0.000
Chapter II Neoplasms	0.075	0.925	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.074	0.926	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.074	0.926	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.074	0.926	0.000
T50.4 Drugs affecting uric acid metabolism	0.074	0.926	0.000
D86.9 Sarcoidosis, unspecified	0.000	0.926	0.074
D86 Sarcoidosis	0.000	0.926	0.074
T50.8 Diagnostic agents	0.073	0.926	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.073	0.926	0.000
T36 Poisoning by systemic antibiotics	0.073	0.927	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.073	0.927	0.000
E04 Other non-toxic goitre	0.000	0.929	0.071
D80-D89 Certain disorders involving the immune mechanism	0.000	0.929	0.071
C73 Malignant neoplasm of thyroid gland	0.071	0.929	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.070	0.929	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.070	0.930	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.069	0.931	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.069	0.931	0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.000	0.932	0.068
C95 Leukaemia of unspecified cell type	0.067	0.932	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.067	0.933	0.000
C02.1 Border of tongue	0.066	0.934	0.000
C93 Monocytic leukaemia	0.066	0.934	0.000
T47.2 Stimulant laxatives	0.066	0.934	0.000
C86 Other specified types of T/NK-cell lymphoma	0.065	0.935	0.000
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.000	0.935	0.065
E55.9 Vitamin D deficiency, unspecified	0.000	0.935	0.065
I45 Other conduction disorders	0.000	0.935	0.065
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.064	0.935	0.000
C94 Other leukaemias of specified cell type	0.064	0.935	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.064	0.936	0.000
I45.9 Conduction disorder, unspecified	0.000	0.936	0.064
C85.1 B-cell lymphoma, unspecified	0.063	0.937	0.000
D86.0 Sarcoidosis of lung	0.000	0.937	0.063
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.063	0.937	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.063	0.937	0.000
T47.7 Emetics	0.063	0.937	0.000
T47.6 Antidiarrhoeal drugs	0.063	0.937	0.000
T47.5 Digestants	0.063	0.937	0.000
T47.4 Other laxatives	0.063	0.937	0.000
T47.3 Saline and osmotic laxatives	0.063	0.937	0.000
T47.0 Histamine H(2)-receptor antagonists	0.063	0.937	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.063	0.937	0.000
T43.6 Psychostimulants with abuse potential	0.063	0.937	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.063	0.937	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.062	0.938	0.000
C74 Malignant neoplasm of adrenal gland	0.062	0.938	0.000
D68 Other coagulation defects	0.000	0.938	0.062
C90.2 Plasmacytoma, extramedullary	0.062	0.938	0.000
C90.0 Multiple myeloma	0.061	0.939	0.000
C02.9 Tongue, unspecified	0.061	0.939	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.061	0.939	0.000
I45.6 Preexcitation syndrome	0.000	0.939	0.061
C45 Mesothelioma	0.061	0.939	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.060	0.939	0.000
T48.5 Anti-common-cold drugs	0.060	0.939	0.000
T48.4 Expectorants	0.060	0.939	0.000
T48.3 Antitussives	0.060	0.939	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.060	0.939	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.060	0.939	0.000
T48.0 Oxytocic drugs	0.060	0.939	0.000
T45.0 Antiallergic and antiemetic drugs	0.060	0.940	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.060	0.940	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.060	0.940	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.060	0.940	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.060	0.940	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.060	0.940	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.060	0.940	0.000
T44.0 Anticholinesterase agents	0.060	0.940	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations